{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T07:52:22Z","timestamp":1781682742471,"version":"3.54.5"},"reference-count":28,"publisher":"Norwegian Medical Association","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"DOI":"10.4045\/tidsskr.17.1115","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T04:57:07Z","timestamp":1543553827000},"source":"Crossref","is-referenced-by-count":6,"title":["Treatment of community-acquired pneumonia"],"prefix":"10.4045","volume":"138","author":[{"given":"Andrea Gran","family":"Berild","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didrik","family":"Erichsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag","family":"Berild","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","published-online":{"date-parts":[[2018,11,26]]},"reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"Welte\u00a0T, Torres\u00a0A, Nathwani\u00a0D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 2012; 67: 71\u20139. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20729232&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136%2Fthx.2009.129502","DOI":"10.1136\/thx.2009.129502"},{"key":"ref=2","unstructured":"Holter\u00a0JC, M\u00fcller\u00a0F, Bj\u00f8rang\u00a0O et al. Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway. BMC Infect Dis 2015; 15: 64. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25887603&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1186%2Fs12879-015-0803-5"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"R\u00f8ysted\u00a0W, Simonsen\u00a0\u00d8, Jenkins\u00a0A et al. Aetiology and risk factors of community-acquired pneumonia in hospitalized patients in Norway. Clin Respir J 2016; 10: 756\u201364. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25764275&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fcrj.12283","DOI":"10.1111\/crj.12283"},{"key":"ref=4","unstructured":"Nasjonal faglig retningslinje for bruk av antibiotika i sykehus. Oslo: Helsedirektoratet, 2016. https:\/\/helsedirektoratet.no\/Retningslinjer\/Antibiotika%20i%20sykehus.pdf (4.10.2018)."},{"key":"ref=5","unstructured":"NORM\/NORM-VET 2016. Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway. Troms\u00f8\/Oslo: NORM\/NORM-VET, 2017. https:\/\/unn.no\/Documents\/Kompetansetjenester,%20-sentre%20og%20fagr%C3%A5d\/NORM%20-%20Norsk%20overv%C3%A5kingssystem%20for%20antibiotikaresistens%20hos%20mikrober\/Rapporter\/NORM%20NORM-VET%202016.pdf (4.10.2018)."},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Lim\u00a0WS, van der Eerden\u00a0MM, Laing\u00a0R et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58: 377\u201382. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12728155&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136%2Fthorax.58.5.377","DOI":"10.1136\/thorax.58.5.377"},{"key":"ref=7","unstructured":"Helsedirektoratet. Metoder og verkt\u00f8y for utarbeiding av nasjonale faglige retningslinjer. https:\/\/helsedirektoratet.no\/metoder-og-verktoy(4.10.2018)."},{"key":"ref=8","unstructured":"Berild\u00a0D, Haug\u00a0JB. Fornuftig bruk av antibiotika i sykehus. Tidsskr Nor Legeforen 2008; 128: 2335\u20139. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19096490&dopt=Abstract"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"McCabe\u00a0C, Kirchner\u00a0C, Zhang\u00a0H et al. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules. Arch Intern Med 2009; 169: 1525\u201331. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19752411&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1001%2Farchinternmed.2009.259","DOI":"10.1001\/archinternmed.2009.259"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Haug\u00a0JB, Berild\u00a0D, Walberg\u00a0M et al. Increased antibiotic use in Norwegian hospitals despite a low antibiotic resistance rate. J Antimicrob Chemother 2011; 66: 2643\u20136. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21903657&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1093%2Fjac%2Fdkr361","DOI":"10.1093\/jac\/dkr361"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Laxminarayan\u00a0R, Duse\u00a0A, Wattal\u00a0C et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis 2013; 13: 1057\u201398. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24252483&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2FS1473-3099(13)70318-9","DOI":"10.1016\/S1473-3099(13)70318-9"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Bauer\u00a0TT, Ewig\u00a0S, Marre\u00a0R et al. CRB-65 predicts death from community-acquired pneumonia. J Intern Med 2006; 260: 93\u2013101. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16789984&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fj.1365-2796.2006.01657.x","DOI":"10.1111\/j.1365-2796.2006.01657.x"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Dwyer\u00a0R, Hedlund\u00a0J, Henriques-Normark\u00a0B et al. Improvement of CRB-65 as a prognostic tool in adult patients with community-acquired pneumonia. BMJ Open Respir Res 2014; 1: e000038. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25478185&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136%2Fbmjresp-2014-000038","DOI":"10.1136\/bmjresp-2014-000038"},{"key":"ref=14","unstructured":"Singer\u00a0M, Deutschman\u00a0CS, Seymour\u00a0CW et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315: 801\u201310. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26903338&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1001%2Fjama.2016.0287"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Kolditz\u00a0M, Scherag\u00a0A, Rohde\u00a0G et al. Comparison of the qSOFA and CRB-65 for risk prediction in patients with community-acquired pneumonia. Intensive Care Med 2016; 42: 2108\u201310. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27647332&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007%2Fs00134-016-4517-y","DOI":"10.1007\/s00134-016-4517-y"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Ranzani\u00a0OT, Prina\u00a0E, Men\u00e9ndez\u00a0R et al. New sepsis definition (sepsis-3) and community-acquired pneumonia mortality. A validation and clinical decision-making study. Am J Respir Crit Care Med 2017; 196: 1287\u201397. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=28613918&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1164%2Frccm.201611-2262OC","DOI":"10.1164\/rccm.201611-2262OC"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"Lindemann\u00a0PC, Haldorsen\u00a0BC, Smith\u00a0I et al. Aminoglykosider b\u00f8r fortsatt brukes i\u00a0empirisk sepsisbehandling. Tidsskr Nor Legeforen 2013; 133: 1054\u20135. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23712163&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.4045%2Ftidsskr.13.0213","DOI":"10.4045\/tidsskr.13.0213"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"Whittaker\u00a0R, Economopoulou\u00a0A, Dias\u00a0JG et al. Epidemiology of invasive haemophilus influenzae disease, Europe, 2007\u20132014. Emerg Infect Dis 2017; 23: 396\u2013404. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=28220749&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.3201%2Feid2303.161552","DOI":"10.3201\/eid2303.161552"},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"H\u00f8gli\u00a0JU, Garcia\u00a0BH, Skjold\u00a0F et al. An audit and feedback intervention study increased adherence to antibiotic prescribing guidelines at a Norwegian hospital. BMC Infect Dis 2016; 16: 96. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26920549&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1186%2Fs12879-016-1426-1","DOI":"10.1186\/s12879-016-1426-1"},{"key":"ref=20","doi-asserted-by":"crossref","unstructured":"Andes\u00a0D, Craig\u00a0WA. Animal model pharmacokinetics and pharmacodynamics: a critical review. Int J Antimicrob Agents 2002; 19: 261\u20138. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11978497&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2FS0924-8579(02)00022-5","DOI":"10.1016\/S0924-8579(02)00022-5"},{"key":"ref=21","doi-asserted-by":"crossref","unstructured":"Lee\u00a0CE, Zembower\u00a0TR, Fotis\u00a0MA et al. The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance. Arch Intern Med 2000; 160: 2819\u201322. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11025792&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1001%2Farchinte.160.18.2819","DOI":"10.1001\/archinte.160.18.2819"},{"key":"ref=22","doi-asserted-by":"crossref","unstructured":"Park\u00a0MA, Li\u00a0JT. Diagnosis and management of penicillin allergy. Mayo Clin Proc 2005; 80: 405\u201310. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15757022&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.4065%2F80.3.405","DOI":"10.4065\/80.3.405"},{"key":"ref=23","doi-asserted-by":"crossref","unstructured":"Borch\u00a0JE, Andersen\u00a0KE, Bindslev-Jensen\u00a0C. The prevalence of suspected and challenge-verified penicillin allergy in a university hospital population. Basic Clin Pharmacol Toxicol 2006; 98: 357\u201362. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16623858&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fj.1742-7843.2006.pto_230.x","DOI":"10.1111\/j.1742-7843.2006.pto_230.x"},{"key":"ref=24","doi-asserted-by":"crossref","unstructured":"Uranga\u00a0A, Espa\u00f1a\u00a0PP, Bilbao\u00a0A et al. Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial. JAMA Intern Med 2016; 176: 1257\u201365. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27455166&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1001%2Fjamainternmed.2016.3633","DOI":"10.1001\/jamainternmed.2016.3633"},{"key":"ref=25","doi-asserted-by":"crossref","unstructured":"el Moussaoui\u00a0R, de Borgie\u00a0CA, van den Broek\u00a0P et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. BMJ 2006; 332: 1355. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16763247&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136%2Fbmj.332.7554.1355","DOI":"10.1136\/bmj.332.7554.1355"},{"key":"ref=26","doi-asserted-by":"crossref","unstructured":"Mandell\u00a0LA, File\u00a0TM. Short-course treatment of community-acquired pneumonia. Clin Infect Dis 2003; 37: 761\u20133. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12955635&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1086%2F377567","DOI":"10.1086\/377567"},{"key":"ref=27","unstructured":"Schuetz\u00a0P, M\u00fcller\u00a0B, Christ-Crain\u00a0M et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev 2012;  9: CD007498. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22972110&dopt=Abstract"},{"key":"ref=28","unstructured":"Grimshaw\u00a0JM, Eccles\u00a0MP, Lavis\u00a0JN et al. Knowledge translation of research findings. Implement Sci 2012; 7: 50. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22651257&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1186%2F1748-5908-7-50"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":["Behandling av pneumoni oppst\u00e5tt utenfor sykehus"],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T07:02:03Z","timestamp":1781679723000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2018\/11\/originalartikkel\/behandling-av-pneumoni-oppstatt-utenfor-sykehus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,26]]},"references-count":28,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2018,11,27]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.17.1115","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,26]]}}}